Thioredoxin in cancer--role of histone deacetylase inhibitors
about
Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factorThe clinical development of histone deacetylase inhibitors as targeted anticancer drugs.Particle size of latex beads dictates IL-1β production mechanism.Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.Histone deacetylase inhibitors: emerging mechanisms of resistance.Targeting Histone Deacetylases in Diseases: Where Are We?B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy.Thioredoxin system: a model for determining novel lead molecules for breast cancer chemotherapy.MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1.Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation.Histone deacetylase inhibitors and cell death.Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy.Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis.A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin.Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry.
P2860
Q33602407-BD3A3F37-3622-4816-82A5-2DF1E5C440EAQ33829390-8D4DF9D5-A199-4FA7-AA17-97EE6FCB2E9CQ34848969-72FDE531-83F9-4E72-B62F-AB656566C2B3Q35214924-7368A37F-709F-4091-9C06-C823C5530CFDQ35592607-AA24F35A-90AD-4E54-9EA4-2FDCA9CD7CB2Q35821728-2B06F5C3-B0CE-4C85-965E-2C03414854E6Q36544467-1025B126-62B5-4D0D-9AD7-0C80E029C300Q36571477-BC15B9B0-1FDA-4FA5-8A73-9D123435A5F4Q36642830-491E3BEF-CC11-4E24-80EF-7BDBE9F2A09DQ36982745-3368AAAD-F117-4F57-B451-E0ABAF577900Q37467846-B667CEF6-DB44-4E09-AE8F-F334ABDD67F5Q38166568-5E1BF293-A209-4F29-BF33-8CC03FFF0502Q38217666-4687C014-AD39-4B39-88EB-14C8EB33178BQ38645501-954DDBDF-AD71-4900-9A06-15912D53F00DQ38707613-C9762FCA-7660-4DBD-BA30-2A05095D4233Q38735021-BF85854B-D06E-427A-9D23-A8E121ECF1E9Q39153903-51E14264-DD5F-4CB5-93CE-A8433869B7B3Q47160397-8AA095D2-D59E-42F9-9AE3-E15A2581C731Q49513092-F6B61A18-F81D-449B-AA27-4C6D50CD88A0
P2860
Thioredoxin in cancer--role of histone deacetylase inhibitors
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Thioredoxin in cancer--role of histone deacetylase inhibitors
@ast
Thioredoxin in cancer--role of histone deacetylase inhibitors
@en
type
label
Thioredoxin in cancer--role of histone deacetylase inhibitors
@ast
Thioredoxin in cancer--role of histone deacetylase inhibitors
@en
prefLabel
Thioredoxin in cancer--role of histone deacetylase inhibitors
@ast
Thioredoxin in cancer--role of histone deacetylase inhibitors
@en
P2860
P1476
Thioredoxin in cancer--role of histone deacetylase inhibitors
@en
P2093
Paul A Marks
P2860
P304
P356
10.1016/J.SEMCANCER.2006.09.005
P577
2006-09-26T00:00:00Z